Skip to main content

Table 5 Lead-ECs for the centres in Austria, France and Switzerland

From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

CountryLead Ethical committee
AustriaEthikkommission der Medizinischen Universität Innsbruck (AM4161b_LEK)
FranceComité de Protection des Personnes EST I (2011–52)
SwitzerlandEthikkommission Ostschweiz (EKSG 10/029)